RT Journal Article
SR Electronic
T1 Diabetes medications and cardiovascular outcome trials: Lessons learned
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 759
OP 767
DO 10.3949/ccjm.84gr.17006
VO 84
IS 10
A1 Patel, Kershaw V.
A1 De Albuquerque Rocha, Natalia
A1 McGuire, Darren K.
YR 2017
UL http://www.ccjm.org/content/84/10/759.abstract
AB The US Food and Drug Administration’s current standards require that new diabetes medications demonstrate cardiovascular safety in large, long-term trials. New drugs that have been assessed in such trials are changing the management of type 2 diabetes.